萌蒂制药的争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 5 条
2024
2019
Mundipharma因TARGIN宣传内容支付罚款
罚款或处罚
Mundipharma因澳大利亚治疗用品管理局发出的24份侵权通知支付302,400澳元罚款。通知涉及九种TARGIN阿片类药物的宣传内容，TGA认为其具有误导性、失衡且存在其他不准确之处；支付罚款并不代表承认过错或责任。
来源摘录
The payment of an infringement notice is not an admission of guilt or liability.
The notices were issued because the TGA formed the view that Mundipharma had breached the conditions of registration for nine TARGIN medicines, alleging that its advertising to health professionals was misleading, imbalanced and otherwise inaccurate, in breach of the requirements of the Medicines Australia Code of Conduct regarding promotional materials directed to health professionals.
Mundipharma Pty Ltd (Mundipharma) has paid penalties of $302,400 in response to 24 infringement notices issued by the Therapeutic Goods Administration (TGA) within the Department of Health.
2019
Mundipharma因Targin广告被罚款
罚款或处罚
澳大利亚治疗用品管理局因Targin宣传材料可能鼓励为慢性非癌症疼痛开具阿片类药物，对Mundipharma处以302,400澳元罚款并发出24份侵权通知。Mundipharma表示不同意该决定。
品牌回应
澄清 — Mundipharma
A spokesperson for Mundipharma said the sentence that the TGA found fault with was intended to “proactively and voluntarily urge caution when healthcare professionals chose to prescribe an opioid,” adding that Mundipharma “respectfully disagrees” with the regulator’s decision but “respects the important role of the TGA” in pharma regulation.
来源摘录
The notices were tied to a single sentence that appeared in promotional materials for Targin, which the TGA said “appeared to positively encourage the prescription of Targin medicines for chronic non-cancer pain.”
The Therapeutic Goods Administration (TGA) said in a statement last week that it fined Mundipharma—a group of companies owned by the Sackler family, which also owns Purdue—AU$302,400 ($209,369) and served the company with 24 infringement notices.